Previous 10 | Next 10 |
Entered into agreements to acquire Cyclica and Valence to bolster digital chemistry and generative AI capabilities in order to further create new chemical composition of matter for novel biological targets Advanced 4 active clinical trials, including an exploratory Phase 2 study of REC-994 in...
SALT LAKE CITY and TORONTO and MONTRÉAL, May 08, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has signed agreements to acquire two companies in the AI-enabled drug disc...
2023-04-27 18:01:59 ET Gainers: Mirati Therapeutics ( MRTX ) +10% . JAKKS Pacific ( JAKK ) +10% . Amazon.com ( AMZN ) +9% . Datadog ( DDOG ) +8% . Recursion Pharmaceuticals ( RXRX ) +6% . Losers: Accolade ( ACCD ) -...
2023-04-06 17:02:48 ET Gainers: Ramaco Resources ( METC ) +5% . Aemetis ( AMTX ) +5% . El Pollo Loco Holdings ( LOCO ) +5% . Independent Bank Corporation ( IBCP ) +2% . SMART Global Holdings ( SGH ) +2% . Losers: Nurix Th...
Salt Lake City, March 28, 2023 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery, today announced the release of its second annual Environmental, Social and Governance (ESG) Report . The rep...
2023-03-17 10:10:00 ET Vancouver, Kelowna, Delta, BC - March 17, 2023 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces its weekly roundup of stocks to watch in Mining, Biotech and Hydrogen. Today's stocks have been added to o...
Salt Lake City, Utah, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Rare Disease advocacy organizations and biotech and healthcare industry leaders will partner to accelerate the diagnosis and improve the care of more than 344,000 Utahns living with a rare disease. On Rare Disease Day, Feb. 28, 2023, communi...
Summary Baillie Gifford’s 13F portfolio value decreased from ~$96.99B to ~$95.96B this quarter. They increased NVIDIA, Shopify, NIO Inc., SEA Ltd., Roblox, DoorDash, and Ginkgo Bioworks while reducing Illumina, Ferrari N.V., Arthur J. Gallagher & Co., Albemarle, Meta Platform...
Recursion Releases MolRec, a Compound Intelligence Tool for Drug Discovery, Alongside the Largest of Its Kind Open-Source Dataset During First R&D Day Recursion Releases MolRec, a Compound Intelligence Tool for Drug Discovery, Alongside the Largest of Its Kind Open-Source Dataset Du...
The following slide deck was published by Recursion Pharmaceuticals, Inc. in conjunction with this event. For further details see: Recursion Pharmaceuticals (RXRX) presents at 41st Annual J.P. Morgan Healthcare Conference - Slideshow
News, Short Squeeze, Breakout and More Instantly...
Recursion Pharmaceuticals Inc. Company Name:
RXRX Stock Symbol:
NASDAQ Market:
Recursion Pharmaceuticals Inc. Website:
Salt Lake City, June 26, 2024 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“ Recursion ”) (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced the pricing of its underwritten public offering of 30,769,...